Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Raises Price Target to $100
إدوارد لايفساينس
Edwards Lifesciences Corporation EW | 0.00 |
Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:
EW) with a Outperform and raises the price target from $93 to $100.
